Neurocrine Biosciences, Inc. (NBIX) Reports In-Line Q1 Loss of 1c

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported Q1 EPS of ($0.01), in-line with the analyst estimate of ($0.01). Revenue for the quarter came in at $11.3 million versus the consensus estimate of $10.84 million.

For earnings history and earnings-related data on Neurocrine Biosciences, Inc. (NBIX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Movano (MOVE) Misses Q2 EPS by 195c